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Activation of the damage-associated molecular pattern receptor P2X7 induces
interleukin-1B release from canine monocytes
Abstract
P2X7, a damage-associated molecular pattern receptor and adenosine 5'-triphosphate (ATP)-gated cation
channel, plays an important role in the activation of the NALP3 inflammasome and subsequent release of
interleukin (IL)-1β from human monocytes; however its role in monocytes from other species including
the dog remains poorly defined. This study investigated the role of P2X7 in canine monocytes, including
its role in IL-1β release. A fixed-time flow cytometric assay demonstrated that activation of P2X7 by
extracellular ATP induces the uptake of the organic cation, YO-PRO-12+, into peripheral blood monocytes
from various dog breeds, a process impaired by the specific P2X7 antagonist, A438079. Moreover, in five
different breeds, relative P2X7 function in monocytes was about half that of peripheral blood T cells but
similar to that of peripheral blood B cells. Reverse transcription-PCR demonstrated the presence of P2X7,
NALP3, caspase-1 and IL-1β in LPSprimed canine monocytes. Immunoblotting confirmed the presence of
P2X7 in LPS-primed canine monocytes. Finally, extracellular ATP induced YO-PRO-12+ uptake into and
IL-1β release from these cells, with both processes impaired by A438079. These results demonstrate that
P2X7 activation induces the uptake of organic cations into and the release of IL-1β from canine
monocytes. These findings indicate that P2X7 may play an important role in IL-1β-dependent processes
in dogs.
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Abstract

P2X7, a damage-associated molecular pattern receptor and adenosine 5’-triphosphate (ATP)-

gated cation channel, plays an important role in the activation of the NALP3 in�lammasome

and subsequent release of interleukin (IL)-1β from human monocytes, however its role in

monocytes from other species including the dog remains poorly de�ined. This study

investigated the role of P2X7 in canine monocytes, including its role in IL-1β release. A �ixed-

time �low cytometric assay demonstrated that activation of P2X7 by extracellular ATP induces

the uptake of the organic cation, YO-PRO-1 2+, into peripheral blood monocytes from various
dog breeds, a process impaired by the speci�ic P2X7 antagonist, A438079. Moreover, in �ive

different breeds, relative P2X7 function in monocytes was about half that of peripheral blood

T cells but similar to that of peripheral blood B cells. Reverse transcription-PCR demonstrated

the presence of P2X7, NALP3, caspase-1 and IL-1β in LPS-primed canine monocytes.
Immunoblotting con�irmed the presence of P2X7 in LPS-primed canine monocytes. Finally,

extracellular ATP induced YO-PRO-12+ uptake into and IL-1β release from these cells, with

both processes impaired by A438079. These results demonstrate that P2X7 activation induces

the uptake of organic cations into and the release of IL-1β from canine monocytes. These

�indings indicate that P2X7 may play an important role in IL-1β-dependent processes in dogs.
Keywords:

damage-associated

molecular

pattern

in�lammasome; interleukin-1β; monocyte; dog

receptor;

purinergic

receptor;

Abbreviations: ATP, adenosine 5’-triphosphate; DAMP, damage-associated molecular

pattern; MFI, mean �luorescence intensity; RT, reverse transcription.
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1. Introduction

Damage-associated molecular patterns (DAMPs) play important roles in in�lammation

and immunity by functioning as signals of cell damage, stress or death during infection, injury

or disease (Kono and Rock, 2008; Chen and Nuñez, 2010). One of the best-characterised

DAMP is extracellular adenosine 5’-triphosphate (ATP), which mediates its effects through

the activation of the P2X7 purinergic receptor, a trimeric ATP-gated cation channel (Bours, et

al., 2011; Wiley, et al., 2011). Activation of P2X7 by extracellular ATP causes the �lux of Ca 2+,
Na+ and K+, as well as the uptake of organic cations such as ethidium + and YO-PRO-12+ (Jarvis
and Khakh, 2009). Furthermore, P2X7 activation induces various downstream events

including the NALP3 in�lammasome-dependent maturation of IL-1β, and its subsequent

release from various myeloid cell types (Di Virgilio, 2007). This event, at least in monocytes,

requires the prior activation of cells with the TLR4 ligand, LPS, which results in the upregulation and assembly of the NALP3 in�lammasome, as well as the synthesis of IL-1β

(Mehta, et al., 2001; Bauernfeind, et al., 2009). Due to this and other properties of P2X7

activation, this receptor plays important roles in human health and disease (Sluyter and

Stokes, 2011), and thus may have similar roles in canine health and disease.

The presence of functional P2X7 on human and murine cell types is well established, but

little is known about P2X7 in other mammalian species including the dog. We have previously

demonstrated that peripheral blood monocytes, lymphocytes and erythrocytes from English

Springer Spaniels express functional P2X7 (Sluyter, et al., 2007; Shemon, et al., 2008;

Stevenson, et al., 2009). In particular, we have previously shown that the relative amount of

P2X7 function in monocytes is about half that of canine T cells but similar to that of B cells

(Stevenson, et al., 2009). Similar studies in other dog breeds however are lacking, and given

that distinct phenotypic traits exist between breeds it remains necessary to examine P2X7 in
3
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additional breeds. Moreover, it remains unknown if P2X7 activation can induce the release of
IL-1β from canine monocytes, and there is a general paucity of studies examining IL-1β
release from canine myeloid cell types. Given the importance of P2X7 in human health and

disease (Sluyter and Stokes, 2011), new knowledge about this receptor and events
downstream of its activation in the dog is necessary to establish and understand the role of

P2X7 in canine health and disease. Therefore, we investigated P2X7 in canine monocytes, and

in particular its role in the release of IL-1β.
2. Materials and methods

2.1. Materials

Ficoll-PaqueTM PLUS was from GE Healthcare Biosciences (Uppsala, Sweden). A438079

was from Tocris Bioscience (Ellisville, MO). ATP and LPS (Escherichia Coli serotype 055:B5)

were from Sigma Chemical Co (St Louis, MO). YO-PRO ®-1 iodide solution, RPMI-1640

medium, L-glutamine and ExoSAP-IT were from Invitrogen (Grand Island, NJ). FCS was from

Bovogen Biologicals (East Keilor, Australia). BigDye Terminator v3.1 was from Applied
Biosystems (Carlsbad, CA).
2.2. Canine monocytes

Peripheral blood was collected into VACUETTE ® lithium heparin tubes (Greiner Bio-

One, Frickenheisen, Germany) from either pedigree or cross breed dogs with informed, signed

consent of pet owners, and with the approval of the University of Wollongong Ethics

Committee (Wollongong, Australia). PBMCs were isolated from buffy coats using Ficoll4
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PaqueTM density centrifugation as described (Stevenson, et al., 2009). To study LPS-primed

monocytes, PBMCs in complete culture medium (RPMI-1640 medium containing 2 mM Lglutamine and 10% FCS) were incubated for 2 h at 37 oC/5% CO2, the non-adherent cells were

removed by gently washing twice with PBS, and the plastic-adherent cells incubated for a
further 4 h in complete culture medium containing 100 ng/ml LPS.
2.3. J774 cells

J774 cells (American Type Culture Collection, Rockville, MD), a murine macrophage

cell line, were maintained in complete culture medium at 37oC/5% CO2.
2.4. Reverse transcription PCR

Total RNA was isolated using the RNeasy® Mini Kit (Qiagen, Hilden, Germany)

according to the manufacturer's instructions. Reverse transcription (RT)-PCR was performed

using Superscript® III One-Step RT-PCR System Platinum Taq DNA polymerase (Invitrogen)

according to the manufacturer’s instructions using primer pairs (GeneWorks, Hindmarsh,

Australia) speci�ic for P2X7, NALP3, caspase-1 or IL-1β mRNA transcripts (Table 1). The
identity of each transcript was con�irmed by sequencing of Exo-SAP-IT puri�ied amplicons
using the above primer pairs with BigDye Terminator and an Applied Biosystems 3130xl

Genetic Analyzer.

2.5. Immunoblotting

5
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Immunoblotting of whole cell lysates was performed using a rabbit anti-rat P2X7

polyclonal Ab (Alomone Labs, Jerusalem, Israel) as described (Constantinescu, et al., 2010).
Immunoblotting demonstrated that this Ab binds a protein corresponding to the predicted

size of glycosylated P2X7 in HEK-293 cells transfected with canine P2X7 cDNA but not in

mock-transfected HEK-293 cells (Spildrejorde and Sluyter, unpublished results).
2.6. YO PRO 12+ uptake assay

ATP-induced YO-PRO-12+ uptake into PBMCs suspended in NaCl medium (145 mM

NaCl, 5 mM KCl, 5 mM glucose, 0.1% BSA, 10 mM HEPES, pH 7.4) was determined using a

�ixed-time �low cytometric assay as described (Gadeock, et al., 2010). To con�irm that ATP-

induced YO-PRO-12+ uptake was mediated by P2X7, cells were pre-incubated in the absence
or presence of 10 μM A438079 for 15 min. Following ATP incubation, cells were then labelled

with PerCP/Cy5.5- or allophycocyanin-conjugated anti-human/canine CD14 mAb (clone

M5E2) (BioLegend, San Diego, CA). To assess YO-PRO-12+ uptake in lymphocytes, cells were

labelled with murine anti-canine CD21-like (clone CA2.1D6) or CD3 (clone CA17.2A12) mAb

(AbD Serotec, Oxford, United Kingdom), and allophycocyanin-conjugated donkey anti-murine

IgG (eBioscience, San Diego, CA). Data was acquired using a LSR II �low cytometer (BD) and
the mean �luorescence intensity (MFI) of YO-PRO-1 2+ uptake determined using FlowJo
software (Tree Star, Ashland, OR).
2.7. IL 1β release assay

ATP-induced IL-1β release from canine monocytes was performed as previously

described for human monocytes (Sluyter, et al., 2004). Brie�ly, PBMCs in complete culture
6
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medium were incubated in 24-well plates (0.625 x 10 6 cells/well) for 2 h at 37oC/5% CO2.

Plates were washed and the plastic-adherent cells incubated for a further 4 h in complete

culture medium containing 100 ng/ml LPS. The plastic-adherent cells were then preincubated in the absence or presence of 50 μM A438079 in RPMI-1640 medium containing

0.1% bovine serum albumin for 15 min, followed by incubation in the absence or presence of

5 mM ATP (0.5 ml/well) for 30 min. Following ATP incubation, samples were centrifuged

(11,000 x g for 30 s) and cell-free supernatants stored at -20 oC until required. The amount of

IL-1β in cell-free supernatants was quanti�ied using a Canine IL-1β VetSetTM ELISA
Development Kit King�isher Biotech (St. Paul, MN) according to the manufacturer's

instructions.

2.8. Statistical analysis

Differences between treatments were compared using either the unpaired Student's t-

test or ANOVA (using Tukey's post test) for single or multiple comparisons, respectively.
Errors are expressed as SDs.
3. Results and discussion

3.1. P2X7 activation induces organic cation uptake into peripheral blood monocytes

To determine if P2X7 activation induces the uptake of an organic cation into

monocytes from additional dog breeds to English Springer Spaniels, ATP-induced YO-PRO-12+

(375 Da) uptake into peripheral blood monocytes from two Staffordshire Bull Terriers and

one Bull Terrier was examined in the absence or presence of A438079, which impairs human,
7
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monkey, rat and murine P2X7 (Donnelly-Roberts, et al., 2009; Bradley, et al., 2011). In the

absence of A438079, ATP induced YO-PRO-1 2+ uptake into peripheral blood monocytes from
all three dogs (Fig. 1A). Pre-incubation with this antagonist impaired ATP-induced YO-PRO-

12+ uptake by 93 ± 13% (Fig. 1A). Thus, P2X7 activation induces the uptake of YO-PRO-12+
into canine peripheral blood monocytes, and the presence of functional P2X7 receptors on

peripheral blood monocytes is not restricted to one breed.

To determine the relative pattern of P2X7 function in leukocytes from various dog

breeds other than English Springer Spaniels, ATP-induced YO-PRO-12+ uptake into peripheral

blood monocytes from �ive different breeds was examined. As above (Fig. 1A), ATP induced

YO-PRO-12+ uptake into peripheral blood monocytes from each dog (Fig. 1B). ATP also

induced YO-PRO-12+ uptake into peripheral blood B and T cells from each dog, with the

average amount of uptake three-fold greater in T cells compared to monocytes and B cells

(range fold increase of 2.7-4.5 and 1.7-3.8, respectively) (Fig. 1B). Thus, a relative pattern of

P2X7 function similar to that observed for English Springer Spaniels (Stevenson, et al., 2009)

is also seen between peripheral blood monocytes, B cells and T cells from �ive other dog

breeds (Australian Bulldog, Border Collie, Bull Terrier, Jack Russell Terrier and Staffordshire

Bull Terrier). The difference between canine monocytes, B cells and T cells most likely relates
to the amount of P2X7 expression, as cell-surface P2X7 expression correlates with P2X7

function in human leukocytes (Gu, et al., 2000). Moreover, the consistent pattern of P2X7

function between leukocyte subsets from the various breeds suggests that the regulation of

P2X7 expression is highly conserved within dogs. The pattern of P2X7 function between

leukocyte subsets from humans is also similar however, in contrast to dogs, P2X7 function is

�ive-fold higher in human peripheral blood monocytes compared to human peripheral blood B

or T cells (Gu, et al., 2000; Stevenson, et al., 2009). Whether these differences between the two

species are of physiological signi�icance remain unknown. Nevertheless, despite these species
8

Page 8 of 19

dissimilarities, it appears likely that functional P2X7 receptors are expressed on peripheral

blood monocytes, B cells and T cells from all dog breeds.

3.2 P2X7 activation induces organic cation uptake into and IL 1β release from LPS
primed monocytes

To determine if P2X7 can induce the release of IL-1β from canine monocytes, the

presence of mRNA transcripts for P2X7 and IL-1β, as well as for the NALP3 in�lammasome

components, NALP3 and caspase-1, were examined in LPS-primed canine monocytes. RT-PCR

demonstrated the presence of mRNA transcripts for all four molecules (Fig. 2A), with

transcripts corresponding to the predicted size (Table 1) for each molecule (results not

shown). Moreover, with the exception of IL-1β (due to its small size of 64 bp), the identity of

each transcript was con�irmed by sequencing (results not shown). No PCR products were

observed in the water control (Fig. 2A).

To determine if LPS-primed canine monocytes express functional P2X7, the presence

of P2X7 protein was examined by immunoblotting. Murine J774 macrophages, which express

P2X7 (Coutinho-Silva, et al., 2005), were used as a positive control. Immunoblotting with an

anti-P2X7 Ab demonstrated the presence of a major band at 75 kDa, the predicted size of

glycosylated P2X7, in both cell types (Fig. 2B). Minor bands were also observed at 60 and 68

kDa in LPS-primed canine monocytes and J774 cells, respectively (Fig. 2B). These minor

bands most likely represent a degradation product and non-glycosylated P2X7, respectively.

To con�irm that P2X7 was functional in LPS-primed canine monocytes, ATP-induced

YO-PRO-12+ uptake was examined in the absence or presence of A438079. In the absence of
A438079, ATP induced YO-PRO-12+ uptake into LPS-primed canine monocytes (Fig. 2C). Pre-

incubation with this antagonist impaired ATP-induced YO-PRO-1 2+ uptake by 97 ± 4% (Fig.
9
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2C). A438079 in the absence of ATP had no signi�icant effect on YO-PRO-12+ uptake compared

to YO-PRO-12+ uptake in the absence of both A438079 and ATP (results not shown). Thus,
LPS-primed canine monocytes from two pure breeds (Australian Kelpie and two Labradors)

and from one cross breed (Border Collie cross Australian Cattle Dog) express functional P2X7

receptors.

Finally, to determine if P2X7 activation induces IL-1β release from LPS-primed canine

monocytes, cells were pre-incubated in the absence or presence of A438079 prior to

incubation in the absence or presence of ATP, and the amount of IL-1β in cell-free

supernatants measured using a canine IL-1β ELISA. In the absence of A438079, ATP induced

IL-1β release from LPS-primed canine monocytes (Fig. 2D). Pre-incubation with this

antagonist impaired ATP-induced IL-1β release by 97 ± 9% (Fig. 2D). A438079 in the absence

of ATP had no signi�icant effect on IL-1β release compared to IL-1β release in the absence of

both A438079 and ATP (results not shown). Thus, P2X7 activation induces the release of IL1β from LPS-primed canine monocytes. To the best of our knowledge, the P2X7-induced IL-1β

release from canine monocytes has not been previously reported, however others, using

peripheral blood from Beagles, have shown that P2X7 activation induces IL-1β release in a

whole-blood assay (Roman, et al., 2009). Collectively, these observations are consistent with

�indings with human monocytes or whole blood (Perregaux, et al., 2000; Mehta, et al., 2001;
Sluyter, et al., 2004; Bauernfeind, et al., 2009), and indicate that P2X7 may also play an
important role in IL-1β-dependent processes in dogs.

3.3. P2X7 and the NALP3 in�lammasome in canine health and disease

P2X7 has an established role in in�lammation and immunity (Bours, et al., 2011; Wiley,

et al., 2011), and related disorders that include in�lammatory arthritis, and neuropathic and
10
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in�lammatory pain (Labasi, et al., 2002; Chessell, et al., 2005). The action of P2X7 in these

circumstances is largely attributed to its release of IL-1β from monocytes and macrophages,

although other in�lammatory mediators may also be involved (Hughes, et al., 2007).

Nonetheless, P2X7 is attracting considerable interest as a therapeutic target in humans

(Donnelly-Roberts and Jarvis, 2007; Arulkumaran, et al., 2011), and it is likely that

compounds that target P2X7 will have similar therapeutic bene�its in dogs. The results also

support the use of the dog as a suitable model to study the role of P2X7 in health and disease,

as well as to test the therapeutic ef�icacy and other pharmacological parameters of P2X7

antagonists before commencing human clinical trials. In regard to this latter point, dogs have

been used to test the bioavailability and half-life of potential P2X7 antagonists for use as

therapeutics in humans (Abberley, et al., 2010; Duplantier, et al., 2011).
3.4. Conclusion

The current study demonstrates that functional P2X7 receptors are present in

peripheral blood monocytes from various breeds, and that the relative P2X7 function in these

cells is about half that of peripheral T cells but similar to that of peripheral blood B cells.

Moreover, the study demonstrates that LPS-primed canine monocytes produce mRNA

transcripts for P2X7 and IL-1β, as well as for the NALP3 in�lammasome components, NALP3
and caspase-1. Finally, the study demonstrates that these cells express P2X7 protein, and that

activation of this receptor induces the uptake of the organic cation, YO-PRO-12+, and the
release of IL-1β. Collectively, these results show that dogs express functional P2X7 receptors,

and that this receptor may play important roles in canine health and disease, and thus may

represent a promising therapeutic target in dogs.
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Figure legends

Fig. 1. P2X7 activation induces organic cation uptake into peripheral blood monocytes. (A)

Canine PBMCs (from a Bull Terrier or two Staffordshire Bull Terriers) in NaCl medium were

pre-incubated in the absence (Control) or presence of 10 μM A438079 at 37oC for 15 min.
PBMCs were then incubated with 1 μM YO-PRO-12+ in the absence or presence of 1 mM ATP at

37oC for 5 min. (B) Canine PBMCs (from various breeds as indicated) in NaCl medium

containing 1 μM YO-PRO-12+ were incubated in the absence or presence of 1 mM ATP at 37 oC
for 5 min. (A,B) Incubations were stopped by MgCl2 solution and centrifugation, the PBMCs

labelled with (A,B) anti-CD14 mAb, or (B) anti-CD21-like or anti-CD3 mAb, and the MFI of YO-

PRO-12+ uptake into monocytes, B cells and T cells, respectively measured by �low cytometry.

ATP-induced YO-PRO-12+ uptake was de�ined as the difference in the MFI of YO-PRO-1 2+

uptake in the presence and absence of ATP for each group. Symbols represent individual dogs;

bars represent group mean; **P<0.01, ***P<0.001 compared to (A) Control or (B) monocytes

or B cells.

Fig. 2. P2X7 activation induces organic cation uptake into and IL-1β release from LPS-primed

monocytes. (A-D) Adherent PBMCs (from various breeds or cross breeds) in complete

medium containing 100 ng/ml LPS were incubated at 37 oC for 4 h. (A) Isolated RNA from LPSprimed monocytes was ampli�ied by RT-PCR using primers speci�ic for various mRNA

transcripts (as indicated) and the products examined by agarose gel electrophoresis. H2O in

place of RNA was used as a negative control. (B) Whole lysates of LPS-primed monocytes

(Mon) or J774 cells were separated by SDS-PAGE, transferred to nitrocellulose membrane and

probed with anti-P2X7 Ab. (C) LPS-primed monocytes in NaCl medium were pre-incubated in

the absence (Control) or presence of 10 μM A438079 at 37 oC for 15 min. Monocytes were
15

Page 15 of 19

then incubated with 1 μM YO-PRO-12+ in the absence or presence of 1 mM ATP at 37 oC for 5

min. Incubations were stopped by MgCl2 solution and centrifugation, the monocytes labelled

with anti-CD14 mAb, and the MFI of YO-PRO-12+ uptake measured by �low cytometry. ATP-

induced YO-PRO-12+ uptake was de�ined as the difference in the MFI of YO-PRO-1 2+ uptake in

the presence and absence of ATP. (D) LPS-primed monocytes in RPMI-1640 medium

containing were pre-incubated in the absence (Control) or presence of 50 μM A438079 at

37oC for 15 min, followed by incubation in the absence or presence of 5 mM ATP for 30 min.

The amount of IL-1β in cell-free supernatants was quanti�ied using an IL-1β ELISA. ATPinduced IL-1β release was de�ined as difference in IL-1β concentration in the presence and

absence of ATP. (C,D) Symbols represent individual dogs; bars represent group mean;

**P<0.01, ***P<0.001 compared to Control.
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Product
Size
(bp)
P2X7

TGCCTCCCATCCCAGCTCCC

94° for 2
240
min, 30
cycles of
94° for 30
s, 59° for
30 s, 72°
for 3.5 min
NALP3
CACTGTCAGCCTTTGGCAGGGT GTCTCCCAGGGCGTTGTGGC
94° for 2
273
min, 40
cycles of
94° for 15
s, 58° for
20 s, 65°
for 45 s
Caspase‐ ACAGACGCTGGGGCTCTCCT
CCCAGGCCCTCCAGCAGACT
94° for 2
339
min, 40
1
cycles of
94° for 15
s, 58° for
30 s, 66°
for 45 s
IL‐1β
TGCAAAACAGATGCGGATAA
GTAACTTGCAGTCCACCGATT 94° for 2 64
min,
40
cycles of
94° for 30
s, 47° for
30 s, 72°
for 2 min
aPrimers were designed for mRNA transcripts of P2X7, NALP3 and caspase‐1 from the
sequences,

NM_001113456.1,

GTCCTGGGAGCCAAAGCGCC

XM_843284.2

and

NM_001003125.1,

respectively

(http://www.ncbi.nlm.nih.gov/gene) using Primer 3 (http://frodo.wi.mit.edu/primer3/).
Primers for the IL‐1β mRNA transcript were previously described (Maccoux, et al., 2007).
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